The second aim of this study was to investigate the associations between DII and the markers of T2D risk, namely, fasting plasma glucose [FPG], glycohemoglobin [HbA1c], fasting serum insulin [FSI], and homeostatic model assessment of insulin resistance index [HOMA-IR]. This evidence concerns the gene INS and Insulin resistance.